Amring Pharmaceuticals Inc. acquires six ANDA’s

by | Mar 9, 2017 | News

March 1, 2017

Amring Pharmaceuticals Inc. acquired six ANDA’s from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture between Luitpold Pharmaceuticals, Inc. and Alphagen Laboratories Inc.  The acquired ANDAs include niche otic and ophthalmic pharmaceuticals that will bring value to our customers and patients.
Read more